Teleflex Incorporated (NYSE:TFX) Receives $267.71 Consensus Target Price from Analysts

Teleflex Incorporated (NYSE:TFX) has earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $268.86.

Several equities research analysts have weighed in on TFX shares. Stephens increased their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Royal Bank of Canada increased their target price on shares of Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $205.00 to $245.00 in a report on Monday, July 1st. Finally, Truist Financial increased their target price on shares of Teleflex from $247.00 to $255.00 and gave the stock a “hold” rating in a report on Monday.

Insider Activity at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.43% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund grew its position in Teleflex by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock valued at $846,000 after purchasing an additional 46 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in Teleflex by 1.9% in the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock valued at $584,000 after purchasing an additional 53 shares in the last quarter. Empirical Finance LLC grew its position in Teleflex by 3.9% in the first quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company’s stock valued at $354,000 after purchasing an additional 58 shares in the last quarter. SRS Capital Advisors Inc. grew its position in shares of Teleflex by 0.3% in the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company’s stock valued at $4,107,000 after acquiring an additional 62 shares during the period. Finally, Wahed Invest LLC grew its position in shares of Teleflex by 8.9% in the 4th quarter. Wahed Invest LLC now owns 798 shares of the medical technology company’s stock valued at $199,000 after acquiring an additional 65 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of TFX stock opened at $235.38 on Friday. Teleflex has a 52-week low of $177.63 and a 52-week high of $257.85. The stock has a market cap of $11.09 billion, a PE ratio of 37.78, a PEG ratio of 2.13 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58. The firm’s 50 day moving average price is $240.35 and its two-hundred day moving average price is $222.68.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $3.33 by $0.09. The company had revenue of $749.70 million for the quarter, compared to analyst estimates of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period last year, the business posted $3.41 earnings per share. As a group, analysts forecast that Teleflex will post 13.97 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.58%. Teleflex’s payout ratio is 21.83%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.